AbCellera Investor Conference Presentation Deck

CORPORATE OVERVIEW COPYRIGHT © ABCELLERA 11 STRATEGY DICTATES THE BUSINESS MODEL We are building a large diversified portfolio that we believe will generate long-term value and superior returns without the volatility and risks normally associated with drug development. Time Investment Revenue Probability of Success Traditional Biotech Model 9-12 years $900M NO revenue 5% AbCellera's Business Model 13 years LARGE investments in capabilities LITTLE revenue in first decade HIGH

View entire presentation